Protalix BioTherapeutics
PLX
#8199
Rank
$0.18 B
Marketcap
$2.39
Share price
-8.08%
Change (1 day)
92.74%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): $5.21 Million USD

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are $53.39 Million USD. a decrease over its 2023 earnings that were of $11.75 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 $5.21 M-55.62%
2023 $11.75 M-199.05%
2022 -$11.87 Million-40.38%
2021 -$19.91 Million-732.31%
2020 $3.14 M-130.53%
2019 -$10.31 Million189.85%
2018 -$3.56 Million-95.29%
2017 -$75.55 Million308.12%
2016 -$18.52 Million-32.37%
2015 -$27.38 Million10.11%
2014 -$24.86 Million-7.59%
2013 -$26.9 Million
2011 -$31.15 Million-19.39%
2010 -$38.65 Million20.87%
2009 -$31.97 Million32.26%
2008 -$24.18 Million-5.46%
2007 -$25.57 Million
2004 -$0.17 Million12.35%
2003 -$0.15 Million-11.1%
2002 -$0.17 Million-57.03%
2001 -$0.39 Million1.03%
2000 -$0.39 Million-53.22%
1999 -$0.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$28.76 Million-651.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.51 B 9,740.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.11 B 212,955.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.29 Billion-5,506.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel